CHANGES IN GLOMERULAR HEMODINAMICS PARAMETERS IN HIPERTENSIVE PATIENTS AFTER TREATMENT WITH LERCANIDIPINE
- Conditions
- HYPERTENSIO
- Registration Number
- EUCTR2004-002232-26-ES
- Lead Sponsor
- HOSPITAL 12 OCTUBRE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
PATIENTS WITH 18 YEARS OLD OR MORE, WITH ESSENCIAL HYPERTENSION, WITHOUT PREVIOUS FARMACOLOGIC TREATMENT
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
SECUNDARY OR SEVERY HYPERTENSION, CRONIC RENAL FAILURE, VASCULAR ILLNESS, TOXIC HABIT
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: TO ASSESS THE CHANGES IN GLOMERULAR FILTRATION PARAMETERS IN PATIENTS WITH HYPERTENSION AFTER 1 AND 12 WEEKS OF TREATMENT WITH LERCANIDIPINE 10-20 MG/DAY;Secondary Objective: TO ASSESS THE CHANGES IN THE RESISTANCE OF CORONARY ARTERY AND THE QUOTIENT AND TO DETERMINATE THE CHANGES IN THE ALBUMIN URINAL EXCRETION;Primary end point(s): CHANGES IN GLOMERULAR FILTRATION PARAMETERS AND THE GLOMERULAR PRESSIO
- Secondary Outcome Measures
Name Time Method